title: A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis.
abstract: OBJECTIVE
  Several trials have compared vertebral augmentation with nonsurgical treatment for vertebral compression fractures. This trial compares the efficacy and safety of balloon kyphoplasty and vertebroplasty.
  
  
  METHODS
  Patients with osteoporosis with 1-3 acute fractures (T5-L5) were randomized and treated with kyphoplasty (n = 191) or vertebroplasty (n = 190) and were not blinded to the treatment assignment. Twelve- and 24-month subsequent radiographic fracture incidence was the primary end point. Due to low enrollment and early withdrawals, the study was terminated with 404/1234 (32.7%) patients enrolled.
  
  
  RESULTS
  The average age of patients was 75.6 years (77.4% female). Mean procedure duration was longer for kyphoplasty (40.0 versus 31.8 minutes, P < .001). At 12 months, 7.8% fewer patients with kyphoplasty (50/140 versus 57/131) had subsequent radiographic fracture, and there were 8.6% fewer at 24 months (54/110 versus 64/111). The results were not statistically significant (P > .21). When we used time to event for new clinical fractures, kyphoplasty approached statistical significance in longer fracture-free survival (Wilcoxon, P = .0596). Similar pain and function improvements were observed. CT demonstrated lower cement extravasation for kyphoplasty (157/214 versus 164/201 levels treated, P = .047). For kyphoplasty versus vertebroplasty, common adverse events within 30 postoperative days were procedural pain (12/191, 9/190), back pain (14/191, 28/190), and new vertebral fractures (9/191, 17/190); similar 2-year occurrence of device-related cement embolism (1/191, 1/190), procedural pain (3/191, 3/190), back pain (2/191, 3/190), and new vertebral fracture (2/191, 2/190) was observed.
  
  
  CONCLUSIONS
  Kyphoplasty and vertebroplasty had similar long-term improvement in pain and disability with similar safety profiles and few device-related complications. Procedure duration was shorter with vertebroplasty. Kyphoplasty had fewer cement leakages and a trend toward longer fracture-free survival.
authors.affiliation: From the Department of Orthopaedic Surgery, University of Arizona College of Medicine (M.D.), Tucson, Arizona mdohm@ortho.arizona.edu.
authors.forename: M
authors.initials: M
authors.lastname: Dohm
authors.affiliation: Utah Valley Interventional Associates and Utah Valley Regional Medical Center (C.M.B.), Provo, Utah.
authors.forename: C M
authors.initials: CM
authors.lastname: Black
authors.affiliation: OrthoMontana (A.D.), Billings, Montana.
authors.forename: A
authors.initials: A
authors.lastname: Dacre
authors.affiliation: Medtronic Spine (J.B.T.), Sunnyvale, California.
authors.forename: J B
authors.initials: JB
authors.lastname: Tillman
authors.affiliation: Aurora Memorial Hospital of Burlington (G.F.), Burlington, Wisconsin.
authors.forename: G
authors.initials: G
authors.lastname: Fueredi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001843:Bone Cements / Q000627:therapeutic use; D005260:Female; D050815:Fractures, Compression / Q000601:surgery*; D006801:Humans; D058498:Kyphoplasty / Q000379:methods*; D008297:Male; D008875:Middle Aged; D061646:Operative Time; D058866:Osteoporotic Fractures / Q000601:surgery*; D016103:Spinal Fractures / Q000601:surgery*; D016896:Treatment Outcome; D054854:Vertebroplasty / Q000379:methods*
chemical_list: D001843:Bone Cements